Insights

Innovative Treatment Ablative Solutions offers a novel chemical renal denervation system for hypertension, providing a potentially more effective and targeted alternative to energy-based systems, which could be attractive to healthcare providers seeking advanced minimally invasive treatments.

Regulatory Progress With FDA 510(k) clearance in the US and CE certification in Europe, the Peregrine System is progressing towards commercialization, creating opportunities to engage early adopters and healthcare providers aiming to incorporate new hypertension therapies.

Strong Investment The company has secured significant funding with a recent Series D round of $91.4 million, signaling investor confidence and a solid financial position to support sales growth and clinical trials, which reassures potential partners about ongoing product development.

Clinical Development Active post-market studies in Europe and upcoming US trials provide opportunities for strategic partnerships with clinicians and hospitals, facilitating clinical adoption and expanded sales channels in the hypertension treatment market.

Market Expansion As a clinical-stage startup with a unique minimally invasive device, there is potential to target vascular specialists and cardiologists in major healthcare markets, particularly through collaborations with hospital systems and medical device distributors interested in innovative hypertension solutions.

Similar companies to Ablative Solutions

Ablative Solutions Tech Stack

Ablative Solutions uses 8 technology products and services including RSS, Beaver Builder, Mailchimp, and more. Explore Ablative Solutions's tech stack below.

  • RSS
    Content Management System
  • Beaver Builder
    Content Management System
  • Mailchimp
    Email
  • Google Fonts API
    Font Scripts
  • Cloudways
    Platform As A Service
  • Contact Form 7
    Web Platform Extensions
  • ExactMetrics
    Web Platform Extensions
  • Conditional Fields for Contact Form 7
    Widgets

Media & News

Ablative Solutions's Email Address Formats

Ablative Solutions uses at least 1 format(s):
Ablative Solutions Email FormatsExamplePercentage
FLast@ablativesolutions.comJDoe@ablativesolutions.com
48%
First@ablativesolutions.comJohn@ablativesolutions.com
2%
Last@ablativesolutions.comDoe@ablativesolutions.com
2%
FLast@ablativesolutions.comJDoe@ablativesolutions.com
48%

Frequently Asked Questions

Where is Ablative Solutions's headquarters located?

Minus sign iconPlus sign icon
Ablative Solutions's main headquarters is located at 301 Edgewater Place, Suite 100. The company has employees across 2 continents, including North AmericaEurope.

What is Ablative Solutions's phone number?

Minus sign iconPlus sign icon
You can contact Ablative Solutions's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ablative Solutions's official website and social media links?

Minus sign iconPlus sign icon
Ablative Solutions's official website is ablativesolutions.com and has social profiles on LinkedInCrunchbase.

What is Ablative Solutions's NAICS code?

Minus sign iconPlus sign icon
Ablative Solutions's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Ablative Solutions have currently?

Minus sign iconPlus sign icon
As of December 2025, Ablative Solutions has approximately 19 employees across 2 continents, including North AmericaEurope. Key team members include Vp Regulatory & Quality: K. C.Director Clinical Affairs: S. G.Director Clinical Trial Safety & Fcss: K. R.. Explore Ablative Solutions's employee directory with LeadIQ.

What industry does Ablative Solutions belong to?

Minus sign iconPlus sign icon
Ablative Solutions operates in the Medical Equipment Manufacturing industry.

What technology does Ablative Solutions use?

Minus sign iconPlus sign icon
Ablative Solutions's tech stack includes RSSBeaver BuilderMailchimpGoogle Fonts APICloudwaysContact Form 7ExactMetricsConditional Fields for Contact Form 7.

What is Ablative Solutions's email format?

Minus sign iconPlus sign icon
Ablative Solutions's email format typically follows the pattern of FLast@ablativesolutions.com. Find more Ablative Solutions email formats with LeadIQ.

How much funding has Ablative Solutions raised to date?

Minus sign iconPlus sign icon
As of December 2025, Ablative Solutions has raised $77M in funding. The last funding round occurred on Jan 03, 2019 for $77M.

When was Ablative Solutions founded?

Minus sign iconPlus sign icon
Ablative Solutions was founded in 2011.

Ablative Solutions

Medical Equipment ManufacturingMassachusetts, United States11-50 Employees

Ablative Solutions is a clinical-stage medical device start-up that is pioneering the novel approach of Transcatheter Perivascular Alcohol Denervation for the treatment of hypertension.  

Hypertension, or high blood pressure, is a modern day epidemic, affecting more than one billion people worldwide and an estimated 67 million in the United States alone.  Often described as "the silent killer", hypertension is strongly associated with heart disease and stroke.  

Increased sympathetic nerve activity plays a key role in the pathophysiology of hypertension.  By disrupting, or "denervating" these sympathetic nerves, clinicians can alter this overactive signaling process and reduce patients' blood pressure.  First-generation approaches using radio-frequency energy produced encouraging results, but these systems are challenged by their inability to reach the target nerves, which lie outside of the treatment range of the energy employed.  

Ablative Solutions has developed the Peregrine System to perform chemical renal denervation, using alcohol as the neurolytic agent, which may have substantial advantages over energy-based systems.  The Peregrine System Infusion Catheter features three equally spaced micro-needles that enable the controlled infusion of a neurolytic agent directly into the perivascular space around the renal arteries, where the sympathetic nerves reside. 

The Peregrine System has received FDA 510(k) clearance for the infusion of diagnostic and therapeutic agent into the perivascular area of the peripheral vasculature.  The device has also received the CE Certificate of Conformity in Europe for the treatment of hypertensive patients.  Ablative Solutions is currently conducting a post-market clinical  study in Europe to secure additional clinical data.  The company is also in the planning stage of a randomized clinical trial in the United States to seek approval for the system's use in the treatment of hypertension.

Section iconCompany Overview

Headquarters
301 Edgewater Place, Suite 100
Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2011
Employees
11-50

Section iconFunding & Financials

  • $77M

    Ablative Solutions has raised a total of $77M of funding over 1 rounds. Their latest funding round was raised on Jan 03, 2019 in the amount of $77Mas a Series D.

  • $1M$10M

    Ablative Solutions's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $77M

    Ablative Solutions has raised a total of $77M of funding over 1 rounds. Their latest funding round was raised on Jan 03, 2019 in the amount of $77Mas a Series D.

  • $1M$10M

    Ablative Solutions's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.